Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fate Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FATE
Nasdaq
8731
https://fatetherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fate Therapeutics Inc
Strength Seen in Mirum Pharmaceuticals, Inc. (MIRM): Can Its 8.0% Jump Turn into More Strength?
- Sep 15th, 2023 10:01 am
Why Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?
- Sep 7th, 2023 3:30 pm
Fate Therapeutics to Present at Upcoming September Investor Conferences
- Aug 31st, 2023 12:00 pm
16 Most Shorted Stocks Right Now
- Aug 29th, 2023 11:30 am
FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss
- Aug 9th, 2023 4:12 pm
Q2 2023 Fate Therapeutics Inc Earnings Call
- Aug 9th, 2023 3:04 pm
Fate Therapeutics (FATE) Reports Q2 Loss, Lags Revenue Estimates
- Aug 8th, 2023 9:15 pm
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
- Aug 8th, 2023 8:01 pm
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
- Jul 28th, 2023 12:00 pm
One Fate Therapeutics Insider Raised Stake By 83% In Previous Year
- Jul 22nd, 2023 12:35 pm
We Think Fate Therapeutics (NASDAQ:FATE) Needs To Drive Business Growth Carefully
- Jul 1st, 2023 2:33 pm
Why Shares of Fate Therapeutics Soared This Week
- Jun 16th, 2023 7:53 pm
Editas (EDIT) Surges 15.5%: Is This an Indication of Further Gains?
- Jun 14th, 2023 10:42 am
Halozyme Therapeutics (HALO) Up 0.7% Since Last Earnings Report: Can It Continue?
- Jun 8th, 2023 3:30 pm
Why Is Axsome (AXSM) Down 2.5% Since Last Earnings Report?
- Jun 7th, 2023 3:30 pm
Fate Therapeutics, Inc.'s (NASDAQ:FATE) Low P/S No Reason For Excitement
- Jun 4th, 2023 12:27 pm
Fate Therapeutics (FATE) Down 17.8% Since Last Earnings Report: Can It Rebound?
- Jun 2nd, 2023 3:31 pm
Fate Therapeutics to Present at Upcoming June Investor Conferences
- May 31st, 2023 12:00 pm
Cathie Wood is Selling These 12 Stocks in 2023
- May 25th, 2023 2:49 pm
Broker Revenue Forecasts For Fate Therapeutics, Inc. (NASDAQ:FATE) Are Surging Higher
- May 8th, 2023 10:05 am
Scroll